AstraZeneca and Daiichi’s drug Enhertu raises hopes for early breast cancer cure

AstraZeneca Plc and Daiichi Sankyo Co.’s cancer drug Enhertu bolstered outcomes for patients with early-stage breast cancer, results that could extend the blockbuster’s reach to tens of thousands more people and move it closer to a potential cure.

from mint - science https://ift.tt/vtykpWE
https://ift.tt/gAjO1YQ